Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3'mRNA-seq in HEPM cells (HEPM ATCC CRL-1486)

ABSTRACT: 3'mRNA-seq in HEPM cells (HEPM ATCC CRL-1486)

PROVIDER: PRJNA716304 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

TFAP2A transcription factor ChIP-seq in HEPM cells (HEPM ATCC CRL-1486)

Project description:We performed a transcription factor (TF) ChIP-seq in human embryonal palatal mesenchyme (HEPM; HEPM ATCC ® CRL-1486™) cells with a polyclonal anitbody against TFAP2A ((ab52222, abcam®, Great Britain) in two replicates.

2022-02-02 | GSE169342 | GEO

3'mRNA-seq in HEPM cells (HEPM ATCC CRL-1486)

Project description:We performed 3'mRNA-seq in human embryonal palatal mesenchyme (HEPM) cells to identify genes expressed in this cellular modell of the developing palate.

2022-02-02 | GSE169341 | GEO

TFAP2A transcription factor ChIP-seq in HEPM cells (HEPM ATCC CRL-1486)

Project description:TFAP2A transcription factor ChIP-seq in HEPM cells (HEPM ATCC CRL-1486)

| PRJNA716303 | ENA

Transcription profiling of human foreskin fibroblasts CRL 2091 (ATCC) serum starved for 48 hours, Serum Stimulation time series

Project description:Foreskin fibroblasts CRL 2091 (ATCC) were serum starved for 48 hours, and harvested at the indicated time points after switching to media with 10% FBS essentially as described (Iyer et al., 1999). RNA from all of the sampled time points were pooled as reference RNA to compare with RNA from individual time points as described (Iyer et al., 1999).

2005-10-31 | E-SMDB-2503 | biostudies-arrayexpress

Transcriptional profiling of mouse CRL-2019 cell line of MH-S cells treated with recombinant PVL versus untreated.

Project description:cDNA microarray of the cellline MH-S cells (ATCC: CRL-2019) that were treated with recombinant PVL (rPVL) versus untreated cells

2010-12-21 | E-MEXP-2513 | biostudies-arrayexpress

crl; Transcriptome comparison of the crl mutant and CDT1-RNAi line

Project description:au13-04_cdtbis; cdt1_bis crl mutants and CDT1-RNAi lines have very similar macroscopic phenotypes as well as identical defects in plastid division and biogenesis. Our goal wwas to determine how much of these similarities originated from similar alterations of gene expression. Plantlets of crl mutant and CDT1-RNAi lines were grown in vitro on MS1/2 medium for 14 days. CDT1-RNAi lines were compared to the corresponding wild-type (Ws), whereas crl mutants were compared to their wild-type siblings and are in the Col0 ecotype.

2013-09-01 | GSE48465 | GEO

RNA-seq of mouse myeloma cell line SP 2/0 cells overexpressed with LOC108168067 against vector control

Project description:We found that a novel gene LOC108168067 mRNA significantly changed in plasma cells. Because of plasmablast-like, mus musculus myeloma SP 2/0 cell line (ATCC® CRL-1581™, https://www.atcc.org/products/all/CRL-1581.aspx) was selected to test the effect of LOC108168067 overexpression on plasmablast/plasma cells. LOC108168067 cDNA (General Biosystems, Anhui, China) was cloned into lentiviral vector LV201 (Fugene Corp., Guangzhou, China) to generate LOC108168067 protein. LOC108168067-expressing LV201 was then transfected into SP 2/0 cells, and stable transfectants were identified by drug selection (Puromycin, Sigma, 10 μg/ml). To explore the effect of on gene expression, we determined mRNA profiles in LOC108168067-overexpressed and vector-transduced SP 2/0 cells by RNA-seq. RNA-seq was done with an Illumina HiSeq 2500 instrument at GENEWIZ, Suzhou, China.

2019-07-31 | E-MTAB-7111 | biostudies-arrayexpress

Expression data from mRNA in complex with EGFR from irradiated human A549 (ATCC CCL185) cells

Project description:Immunoprecipitation of EGFR from irradiated A549 (ATCC CCL185) cells was performed in order to characterize bound mRNA species with the help of microarray analysis As control experiment, immunoprecipitation was also performed with IgG

2017-12-21 | GSE92428 | GEO

CSN5i-3 induces degradation of selective CRL substrate receptors and accumulation of CRL substrates

Project description:In this study, we used quantitative proteomics mass spectrometry with 16-plex TMT labeling to compare individual protein levels of DMSO and 1 μM CSN5i-3-treated K562 cells for 2, 8, and 24 hours. CSN5i-3 is a selective and potent inhibitor of Cop9 Signalosome (CSN), which regulates the activity of Cullin-RING E3 ubiquitin ligases (CRLs). CSN5i-3 treatment resulted in reduced CSN activity, and consequently increased cullin neddylation and constitutively active CRL. Gene Ontology analysis of the changed proteins between DMSO- and CSN5i-3-treated samples showed the enrichment of CSN subunits, cell cycle and chromosome-related components, and phosphatase complex, which include multiple CSN subunits (e.g., CSN7B and CSN5), components of CRLs, especially CRL SRs (e.g., SKP2, ELOA and DCAF1/VPRBP), and known substrates of CRLs (e.g., MAGEA6, GLUL, and RHOB). Indeed, eight out of the top 20 most decreased proteins were CRL adaptor and substrate receptors, two out of the top 20 were E2 proteins (CDC34/UBE2R1 and UBE2R2), and two were CSN subunits. Eight out of the top 20 most increased proteins were reported CRL substrates.

2022-09-05 | PXD027862 | Pride

The primary transcriptome of Acinetobacter baumannii ATCC 17978

Project description:Transcriptomics by RNA-seq provides unparalleled insight into bacterial gene expression networks, enabling a deeper understanding of the regulation of pathogenicity, mechanisms of antimicrobial resistance, metabolism, and other cellular processes. Here we present the transcriptome architecture of Acinetobacter baumannii ATCC 17978, a species emerging as a leading cause of antimicrobial resistant nosocomial infections. Differential RNA-seq (dRNA-seq) examination of model strain ATCC 17978 in 16 laboratory conditions identified 3731 transcriptional start sites (TSS), and 110 small RNAs, including the first identification of 22 sRNA encoded at the 3′ end of mRNA.

2018-06-25 | GSE103244 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data